These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12236169)

  • 21. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Firoozi F; Longhurst PA; White MD
    BJU Int; 2005 Jul; 96(1):164-8. PubMed ID: 15963142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of erectile dysfunction. Hard facts support sildenafil].
    MMW Fortschr Med; 2003 Sep; 145(35-36):50-1. PubMed ID: 14584211
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral drug treatment of erectile dysfunction.
    Int J Impot Res; 2003 Dec; 15 Suppl 7():S27-9. PubMed ID: 14695970
    [No Abstract]   [Full Text] [Related]  

  • 24. Chapter 1: The management of erectile dysfunction: an AUA update.
    Montague DK; Jarow JP; Broderick GA; Dmochowski RR; Heaton JP; Lue TF; Milbank AJ; Nehra A; Sharlip ID;
    J Urol; 2005 Jul; 174(1):230-9. PubMed ID: 15947645
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
    Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
    Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epimedium brevicornum Maxim extract relaxes rabbit corpus cavernosum through multitargets on nitric oxide/cyclic guanosine monophosphate signaling pathway.
    Chiu JH; Chen KK; Chien TM; Chiou WF; Chen CC; Wang JY; Lui WY; Wu CW
    Int J Impot Res; 2006; 18(4):335-42. PubMed ID: 16395327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Some aspects of erectile dysfunction pathogenesis and treatment in patients with obesity].
    Ametov AS; Teodorovich OV; Kondrat'eva LV; Popova AIu
    Ter Arkh; 2006; 78(2):92-4. PubMed ID: 16613108
    [No Abstract]   [Full Text] [Related]  

  • 28. [The treatment options broaden. New chances for libido].
    Einecke U
    MMW Fortschr Med; 2002 May; 144(19):4-6. PubMed ID: 12116552
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparison of efficacy and safety of phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction].
    Chen Q; Wang N; Yao F; Lu X
    Zhonghua Nan Ke Xue; 2004 Apr; 10(4):302-4. PubMed ID: 15148932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of nitric oxide in erectile dysfunction: implications for medical therapy.
    Burnett AL
    J Clin Hypertens (Greenwich); 2006 Dec; 8(12 Suppl 4):53-62. PubMed ID: 17170606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Erectile dysfunction: an update on new therapeutic options].
    Roumeguère T
    Acta Urol Belg; 2000; 68(2):41-2. PubMed ID: 11098588
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacology of erectile dysfunction in man.
    Cirino G; Fusco F; Imbimbo C; Mirone V
    Pharmacol Ther; 2006 Aug; 111(2):400-23. PubMed ID: 16443277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat.
    de Tejada IS
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S40-2. PubMed ID: 15224136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erectile dysfunction: expectations beyond phosphodiesterase type 5 inhibition.
    Aversa A; Pili M; Fabbri A; Spera E; Spera G
    J Endocrinol Invest; 2004 Feb; 27(2):192-206. PubMed ID: 15129818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erectile dysfunction: the Viagra revolution.
    Harv Mens Health Watch; 2005 Apr; 9(9):1-6. PubMed ID: 18217258
    [No Abstract]   [Full Text] [Related]  

  • 36. Rapid nitric oxide-induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme.
    Mullershausen F; Russwurm M; Thompson WJ; Liu L; Koesling D; Friebe A
    J Cell Biol; 2001 Oct; 155(2):271-8. PubMed ID: 11604422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?
    Carson CC
    BJU Int; 2006 Apr; 97 Suppl 2():39-43; discussion 44-5. PubMed ID: 16507053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of erectile dysfunction in 2005].
    Porst H
    Urologe A; 2003 Oct; 42(10):1330-6. PubMed ID: 14569381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of DA-8159, a new PDE5 inhibitor, for inducing penile erection in rabbits with acute spinal cord injury.
    Ahn BO; Kang KK; Ahn GJ; Kwon JW; Kim WB; Kang KS; Lee YS
    Int J Impot Res; 2003 Dec; 15(6):405-11. PubMed ID: 14671658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent insights into androgen action on the anatomical and physiological substrate of penile erection.
    Gooren LJ; Saad F
    Asian J Androl; 2006 Jan; 8(1):3-9. PubMed ID: 16372114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.